Self-Assembled Multiepitope Nanovaccine Provides Long-Lasting Cross-Protection against Influenza Virus.
Nie J, Wang Q, Li C, Zhou Y, Yao X, Xu L, Chang Y, Ding F, Sun L, Zhan L, Zhu L, Xie K, Wang X, Shi Y, Zhao Q, Shan Y.
Nie J, et al. Among authors: zhao q.
Adv Healthc Mater. 2024 Apr;13(10):e2303531. doi: 10.1002/adhm.202303531. Epub 2023 Nov 27.
Adv Healthc Mater. 2024.
PMID: 37983728